Co-Diagnostics Inc
CODX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.56M
Close$
$7.86
427.6% upside
Current Fair Value
427.6% upsideUndervalued by 427.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.56 Million |
|---|---|
| Enterprise Value | $-259,096.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-35.25 |
| Beta | 2.88 |
| Outstanding Shares | 4,309,997 |
Return
| Return on Equity | -370.16% |
|---|---|
| Return on Assets | -283.63% |
| Return on Invested Capital | -343.85% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0.28 |
| Price to Sales | - |
| Price to Book Ratio | 0.5 |
| Enterprise Value to Revenue | -0.36 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -7.05 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-3.00
Average shareholder expectationRevenue Estimate
$132,576
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 13.55% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.18%▼ 11.71% |
|---|---|
| Total Invested | $91,501▼ 90.27% |
| Investors Holding | 14▼ 18.00% |
ESG Score
No data
About Co-Diagnostics Inc
CEO: Dwight Egan